Last reviewed · How we verify

NCT03443102

Long-term Assessment of Organ Functions Among Survivors of Severe Acute Respiratory Syndrome

Status unknown Last updated 26 February 2018
What this trial tests

trial in SARS Virus in 150 participants. Status unknown.

Timeline
25 January 2018
Primary endpoint
1 July 2018
1 December 2018

Quick facts

Lead sponsorPeking University People's Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment150
Start date25 January 2018
Primary completion1 July 2018
Estimated completion1 December 2018
Sites1 location across China

Conditions studied

Sponsor

Peking University People's Hospital

Who can join

Eligibility, any sex, with SARS Virus or Long-Term Survivors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

SARS-CoV has caused severe epidemic respiratory disease in human populations. By July 2003, a total of 8,096 probable cases of SARS had been reported including 774 deaths in 27 countries, around one-third of which were health care workers (HCWs). Previous studies have been reported about long-term impacts of SARS infection, including lung function deficiency, steroid-induced osteonecrosis, reduced exercise capacity, and impairment in health-related quality of life (HRQoL). HCWs, especially nurses, have been reported to experience greater psychological distress, particularly increased levels of posttraumatic stress symptomatology (PTSS). But the very complex impacts of this fatal infection on HCWs have not been fully elucidated. It is thus important to follow these occupational patients to detect and manage multi-organ sequelae and functional impairment.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study.
    Zhang P, Li J, Liu H, Han N, et al · · 2020 · cited 315× · PMID 32128276 · DOI 10.1038/s41413-020-0084-5
  2. Investigation of the impact of SARS-CoV infection on the immunologic status and lung function after 15 years.
    Li J, Zheng Y, Zhao L, Yue Z, et al · · 2021 · cited 4× · PMID 34819019 · DOI 10.1186/s12879-021-06881-3
  3. Investigation of the Impact of SARS-CoV-1 Infection on the Immunologic Status and Lung Function After 15 Years
    Li J, Zheng Y, Zhao L, Yue Z, et al · · 2021 · DOI 10.21203/rs.3.rs-386485/v1
  4. Long-term consequences in lung and bone associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study
    Zhang P, Li J, Han N, Liu H, et al · · 2018

Verify or expand the search:

Other Peking University People's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03443102.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing